News & Events

News
  • Published: 20. Oct 2021

How cancer cells evade the immune system

Mutations in cancer-suppressing genes that block cell growth may explain why some cancers evade the body’s immune system, scientists…

News
  • Published: 11. Oct 2021

Molecular boost for cancer immunotherapies

Scientists have identified a new synthetic molecular code that could improve a patient’s response to an effective cancer treatment,…

Events
  • 24. Sep 2021 - 26. Sep 2021

Celebrating our inaugural virtual RGCC Gathering

Zug, Switzerland

RGCC Network doctors from across the world set their alarm clocks and tuned in for RGCC’s first ever virtual…

News
  • Published: 29. Sep 2021

Researchers identify a key enzyme in tumours

Researchers have identified a key enzyme that cancerous tumours rely on to grow and spread within the body. Described…

News
  • Published: 17. Sep 2021

ctDNA accurate at diagnosing rectal cancer relapse

Combining circulating tumour DNA (ctDNA) with magnetic resonance imaging (MRI) can more accurately predict the likelihood of locally advanced…

News
  • Published: 1. Sep 2021

Measuring circulating tumour DNA can improve bladder cancer treatment

The presence of circulating tumour DNA (ctDNA) is a crucial biomarker for patients with bladder cancer (urothelial carcinoma) researchers…

News
  • Published: 19. Aug 2021

Promising new immunotherapy for colorectal cancer patients

Patients with advanced colorectal cancer can benefit from treatment with advanced immunotherapy, known as immune checkpoint inhibitor PD-1/PD-L1, scientists…

News
  • Published: 23. Jul 2021

New breast cancer therapy a step closer to clinical trials

An advanced cancer therapy developed by RGCC scientists has been categorised as a Cell Therapy Medicinal Product (CTMP) by the European…

News
  • Published: 21. Jul 2021

Activating p53 protein improves cancer-killing potential

Activating protein p53 can boost a patient's immune response against cancerous tumours, researchers at Sweden's Karolinska Institutet have discovered.…

News
  • Published: 23. Jun 2021

RGCC scientists develop novel new approach to inhibiting SARS-COV-2 replication

RGCC researchers have developed a new approach to tackling COVID-19 (SARS-CoV-2) that could form the basis of a new…

News
  • Published: 7. Jun 2021

New cancer vaccine effective in 75% of tumours

A new cancer vaccine is 75% effective at eliminating cancerous tumours in mice, say scientists at the University of…

News
  • Published: 24. May 2021

New blood test can diagnose cancer without tumour sample

US scientists have developed the world's first 'tumour-uninformed' test that can detect cancer DNA circulating in the blood of…